stocksGLAXO
GLAXO

Glaxosmithkline Pharmaceuticals Ltd.

2,404.70-29.0 (-1.19%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Glaxosmithkline Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results—————
Conference Calls—————————
Presentations—————————————

Corporate Announcements and Regulatory Filings

Glaxosmithkline Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Board Meeting13 Oct 2026
    Board Meeting Intimation for To Consider, Approve And Take On Record The Un-Audited Financial Results For The Second Quarter & Half Year Ended 30Th September 2026.
    Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve As per attachment
  2. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201812 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    As per attachment
  3. Closure of Trading Window25 Sept 2026
    Closure of Trading Window
    As per attachment
  4. Postal Ballot15 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    As per attachment
  5. Postal Ballot15 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Outcome of Postal Ballot
  6. Newspaper Publication2 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    As per attachment
  7. Postal Ballot1 Sept 2026
    Corrigendum To The Notice Of Postal Ballot Dated August 3, 2026
    As per attachment
  8. General26 Aug 2026
    Volume Movement Letter
    As per attachment
  9. General19 Aug 2026
    Disclosure Under Regulation 30
    As per attachment
  10. Newspaper Publication14 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    As per attachment
  11. Postal Ballot13 Aug 2026
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
    As per attachment
  12. Analyst / Investor Meet6 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Transcript
  13. General6 Aug 2026
    Disclosure Under Regulation 30
    IT Refund of Rs 52 crores
  14. Analyst / Investor Meet5 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    As per attachment
  15. Newspaper Publication4 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    As per attachment
  16. Analyst / Investor Meet3 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    As per attachment
  17. Change in Management3 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Reappointment of Managing Director
  18. Resignation of Director3 Aug 2026
    Announcement under Regulation 30 (LODR)-Resignation of Director
    As per attachment
  19. Change in Directorate3 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    As per attachment
  20. Press Release / Media Release3 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    As per attachment

Frequently Asked Questions

Where can I download the annual report of Glaxosmithkline Pharmaceuticals Ltd.?
Annual reports of Glaxosmithkline Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Glaxosmithkline Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Glaxosmithkline Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Glaxosmithkline Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Glaxosmithkline Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Glaxosmithkline Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Glaxosmithkline Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Glaxosmithkline Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Glaxosmithkline Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Glaxosmithkline Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Glaxosmithkline Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Glaxosmithkline Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Glaxosmithkline Pharmaceuticals Ltd. is INE159A01016. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Glaxosmithkline Pharmaceuticals Ltd. listed?
Glaxosmithkline Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is GLAXO and the BSE code is -.
Where can I find the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Glaxosmithkline Pharmaceuticals Ltd. on Sharpely?
Share price data for Glaxosmithkline Pharmaceuticals Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.